Clinical studies found a beneficial effect of NAC on the dopaminergic system in Parkinson’s disease patients, along with increased dopamine-transporter (DAT) binding in the caudate and the putamen [37, 39]. This evidence concerns the gene SLC6A3 and Parkinson disease.